International Coalition for Drug Awareness
A Group of physicians, researchers, Journalists and concerned citizens dedicated to educating about the dangers posed by many Rx medicines.
WASHINGTON, April 16 (Bloomberg News) — Glaxo- SmithKline P.L.C. has won the
Food and Drug Administration’s approval to market its antidepressant Paxil
for treating general anxiety disorder, a new use for the drug.
That makes Paxil the first drug in its class to be approved for the
condition, which affects about 10 million Americans and involves excessive,
often debilitating worrying, the company said today.
By pure coincidence, two documentaries on two different
channels are arriving back to back tonight and tomorrow to
examine the same issue: the widening and sometimes
harrowing use of psychoactive drugs in America to modify
children’s behavior. Suffice it to say that the programs ˜ the first
on A&E, the other on PBS ˜ are in many ways redundant.
Here’s an insightful interview from the New York Time with Mr. John Horgan, entitled “A Heretic Takes On the Science of the Mind.” In 1996, Mr. Horgan, then a senior writer with The Scientific American, published “The End of Science: Facing the Limits of Knowledge in the Twilight of the Scientific Age,” a 281-page essay…